March 3, 2020 / 3:23 PM / a month ago

BRIEF-Sunesis Pharmaceuticals Says Estimates That Cash, Cash Equivalents, Restricted Cash, Marketable Securities As Of Dec 31, 2019 Was About $34.6 Million

March 3 (Reuters) - Sunesis Pharmaceuticals Inc:

* SUNESIS PHARMACEUTICALS - ESTIMATES THAT CASH, CASH EQUIVALENTS, RESTRICTED CASH, MARKETABLE SECURITIES AS OF DEC 31, 2019 WAS ABOUT $34.6 MILLION Source text: (bit.ly/2TlAbgN) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below